Related by context. All words. (Click for frequent words.) 73 BAY #-# 70 PARP inhibitors 69 angiogenesis inhibitor 69 molecularly targeted 68 pertuzumab 68 LY# [003] 68 XmAb# 68 protein kinase inhibitor 68 vemurafenib 68 SU# [003] 68 PARP inhibitor 68 EGFR inhibitors 67 Zolinza 67 proteasome inhibitor 67 BRAF inhibitor 67 tyrosine kinase inhibitor 67 AP# [003] 67 Pertuzumab 67 Bortezomib 67 obatoclax 66 Aurora kinase 66 ganetespib 66 MEK inhibitor 66 OXi# 66 T DM1 66 HGS ETR1 66 vascular disrupting agent 66 PI3K inhibitor 66 HDAC inhibitors 66 Mipomersen 66 PXD# 66 Yervoy 65 ixabepilone 65 hedgehog pathway 65 tafamidis 65 Dasatinib 65 enzastaurin 65 gefitinib Iressa 65 T#I [002] 65 proteasome inhibitors 65 dacetuzumab 65 IMC A# 65 Hycamtin 65 carfilzomib 65 OMP #M# 65 axitinib 65 imatinib Gleevec 65 Erbitux cetuximab 65 targeting CD# 65 Crizotinib 65 IAP inhibitors 65 vorinostat 65 CCX# 65 bortezomib Velcade 65 Sorafenib 64 multi kinase inhibitor 64 cediranib 64 INCB# [001] 64 Trastuzumab 64 kinase inhibitors 64 Gleevec resistant 64 abiraterone 64 multitargeted 64 Tarvacin 64 vascular disrupting agents 64 histone deacetylase inhibitors 64 OncoVEX GM CSF 64 DFMO 64 lapatinib Tykerb 64 endostatin 64 Nexavar ® 64 CA4P 64 Debio 64 Sym# 64 AMN# [001] 64 HuMax CD# 64 olaparib 64 cilengitide 64 decitabine 64 crizotinib 64 immunomodulator 64 pomalidomide 64 SCH # 64 antitumor 64 Traficet EN 64 ATL# [001] 64 huC# DM4 64 Daclizumab 64 anticancer agent 63 Herceptin trastuzumab 63 Carfilzomib 63 humanized antibody 63 Onconase 63 sapacitabine 63 PEG SN# 63 EndoTAG TM -1 63 TREANDA 63 bendamustine 63 talabostat 63 dasatinib Sprycel 63 LY# [002] 63 dexpramipexole 63 gamma secretase inhibitor 63 JAK inhibitor 63 MGCD# [001] 63 Imatinib 63 tanespimycin 63 erlotinib 63 Plexxikon 63 Targretin 63 Velcade bortezomib 63 erlotinib Tarceva 63 HGS# 63 YONDELIS 63 Symadex 63 anti angiogenic 63 humanised monoclonal antibody 63 DXL# 63 Treanda 63 sorafenib 63 preclinically 63 TACI Ig 63 IMC #B 63 OncoVEX 63 Bezielle 63 Maraviroc 63 sorafenib Nexavar 63 gastrointestinal stromal tumors 63 elesclomol 63 kinase inhibitor 63 Erlotinib 63 ENMD # 63 ZOLINZA 63 antiangiogenesis 63 rituximab Rituxan 63 AEG# 63 antiangiogenic 63 valopicitabine 63 GVAX 63 HCV protease inhibitor 63 Vandetanib 62 topotecan 62 ponatinib 62 Tyrima 62 CBLC# 62 MEK inhibitors 62 receptor tyrosine kinase inhibitor 62 humanized monoclonal antibody 62 Perifosine 62 signal transduction inhibitor 62 seliciclib 62 darapladib 62 mapatumumab 62 Tarceva 62 histone deacetylase HDAC inhibitor 62 PSMA ADC 62 metastatic renal cell carcinoma 62 Gefitinib 62 Abraxane 62 pegfilgrastim 62 TG# [003] 62 mTOR inhibitor 62 HuLuc# 62 integrase inhibitor 62 Amrubicin 62 XL# [003] 62 Tarceva erlotinib 62 temozolomide 62 Gleevec 62 Ceflatonin 62 Pemetrexed 62 Advexin 62 Sphingomab 62 Omacetaxine 62 regorafenib 62 anti angiogenic agent 62 GRN#L 62 Dapagliflozin 62 ALK inhibitor 62 bortezomib 62 tyrosine kinase inhibitors 62 SRT# [003] 62 chemotherapeutic agent 62 Telcyta 62 cetuximab Erbitux 62 paclitaxel Taxol 62 Gleevec imatinib 62 CYT# 62 trastuzumab Herceptin 62 anticancer therapy 62 odanacatib 62 IAP inhibitor 62 Aflibercept 62 Blinatumomab 62 trabectedin 62 Nexavar sorafenib 62 elacytarabine 62 alvespimycin 62 ASA# 62 Proxinium TM 62 RGB # 62 BNC# 62 Azedra 62 farletuzumab 62 imatinib 62 deforolimus 62 Xcytrin 62 Abiraterone 62 chemotherapeutic drug 62 Actilon 62 anticancer agents 62 IGF 1R 62 Abiraterone acetate 62 docetaxel Taxotere ® 62 metaglidasen 62 EGFR tyrosine kinase inhibitors 62 Panzem 62 VEGF inhibitors 61 eniluracil 61 Elotuzumab 61 Atrasentan 61 VEGF Trap 61 EGFr 61 BCR ABL 61 EGF receptor 61 Amplimexon 61 trastuzumab DM1 61 temsirolimus 61 anticancer compound 61 oral antiviral 61 bortezomib Velcade R 61 bevacizumab Avastin 61 Bevacizumab 61 NEUGENE 61 Onco TCS 61 Xanafide 61 ipilimumab 61 entinostat 61 Tarvacin TM 61 Nanobody 61 HuMax CD4 61 HSP# inhibitor 61 flavopiridol 61 Affinitak 61 cabazitaxel 61 Rasagiline 61 elotuzumab 61 Everolimus 61 MetMAb 61 SERMs 61 anti angiogenic drugs 61 Erbitux 61 Imprime PGG 61 phase IIb clinical 61 Annamycin 61 epothilone 61 BMS # 61 NXL# 61 bortezomib Velcade ® 61 Enzastaurin 61 cytostatic 61 oxidative stress inducer 61 alkylating agent 61 cancer immunotherapies 61 liposomal formulation 61 HGS ETR2 61 JAK inhibitors 61 FLT3 61 EGFRvIII 61 Seliciclib 61 alpha folate receptor 61 VEGF receptor 61 neuroprotectant 61 Laquinimod 61 TNFα 61 fulvestrant 61 Epratuzumab 61 tezampanel 61 rindopepimut 61 cetuximab Erbitux ® 61 Gleevec imatinib mesylate 61 ridaforolimus 61 docetaxel chemotherapy 61 Novartis Gleevec 61 ASONEP 61 thalidomide Thalomid 61 vandetanib 61 GRN# 61 Theratope 61 fostamatinib disodium 61 Cytoxan 61 Gemcitabine 61 imetelstat 61 Velcade 61 Doxorubicin 61 epothilones 61 lapatinib 61 BRAF inhibitors 61 Lapatinib 61 Panzem R NCD 61 radezolid 60 Sprycel 60 chimeric monoclonal antibody 60 Vorinostat 60 aflibercept 60 docetaxel Taxotere R 60 antisense 60 anti TNF 60 pan HDAC inhibitor 60 CDK inhibitor 60 interferon beta 60 Factor Xa inhibitor 60 anti angiogenesis 60 corticosteroid dexamethasone 60 anti CD3 antibody 60 IMA# 60 radiation sensitizer 60 PKC# 60 Boceprevir 60 perifosine 60 microtubule inhibitor 60 sorafenib tablets 60 HCV protease inhibitors 60 mertansine 60 Romidepsin 60 antibody fragment 60 VEGFR2 60 depsipeptide 60 Reolysin 60 Olaparib 60 Nexavar 60 PI3K/Akt pathway inhibitor 60 bleomycin 60 Anticalin 60 gefitinib 60 biologic therapy 60 volociximab 60 Sutent 60 VAPRISOL 60 erlotinib Tarceva ® 60 #ME# 60 Cladribine 60 Pathway Inhibitor 60 nucleoside analog 60 elvitegravir 60 galiximab 60 WT1 60 milatuzumab 60 otelixizumab 60 mTOR inhibitors 60 CCR5 antagonists 60 rNAPc2 60 Epidermal Growth Factor Receptor 60 Cisplatin 60 Azixa 60 fusion inhibitor 60 INCB# [002] 60 Cethrin 60 vidofludimus 60 BZL# 60 Vilazodone 60 Revlimid lenalidomide 60 Omnitarg 60 investigational therapies 60 EGFR TKI 60 Ixempra 60 anticancer therapies 60 castration resistant prostate cancer 60 CGEN # 60 RG# [001] 60 Avastin bevacizumab 60 GAP #B# 60 KNS # 60 BiTE antibody 60 orally bioavailable 60 HER2 positive metastatic breast 60 mAb 60 FTY# 60 oncolytic 60 tremelimumab 60 idarubicin 60 somatostatin analogue 60 CCR5 antagonist 60 Anti VEGF 60 methylnaltrexone 60 SNT MC# 60 Apixaban 60 iniparib 60 nonsmall cell lung cancer 60 EZN 60 Rituxan 60 Irinotecan 60 CD# antibody [001] 60 EOquin 60 AMD# [003] 60 romidepsin 60 miR #a [002] 60 novel peptide 60 dasatinib 60 metastatic hormone refractory 60 lumiliximab 60 CYC# 60 NNRTIs 60 CoFactor 60 GLPG# 60 Zactima 60 daclizumab 60 raltegravir 60 NVA# 60 gamma secretase inhibitors 60 targeted radiotherapeutic 60 Rituximab 60 belinostat 60 rhIL 7 60 Interferon alpha 60 JAK3 60 Amigal 60 Elvitegravir 60 MDV# 60 Talabostat 59 anti angiogenic therapy 59 investigational humanized monoclonal antibody 59 histone deacetylase inhibitor 59 humanized anti 59 selective androgen receptor modulator 59 viral kinetics 59 BRAF mutation 59 imatinib mesylate Gleevec 59 sunitinib 59 Xinlay 59 panitumumab 59 systemically administered 59 MGd 59 PDE4 inhibitor 59 MAGE A3 ASCI 59 alefacept 59 anti leukemic 59 OncoVex 59 VA# [002] 59 TRV# [001] 59 anti VEGF 59 atacicept 59 Aurora kinase inhibitor 59 ZD# [001] 59 CDP# 59 taxanes 59 gemcitabine Gemzar 59 oral anticancer 59 Anacetrapib 59 liposomal doxorubicin 59 tasocitinib 59 tarenflurbil 59 Hsp# inhibitors 59 ELACYT 59 Nanobodies 59 luteinizing hormone releasing 59 Hsp# inhibition 59 Telaprevir 59 SPC# [001] 59 Sapacitabine 59 relapsed ovarian cancer 59 omacetaxine 59 IRX 2 59 HDAC inhibitor 59 Genasense 59 soluble receptor 59 oral prodrug 59 PTK ZK 59 Reverset 59 Campath 59 IgG1 monoclonal antibody 59 Deforolimus 59 tesmilifene 59 trabedersen 59 Tanespimycin 59 phase IIa clinical 59 PF # [001] 59 Alemtuzumab 59 indibulin 59 renin inhibitors 59 histone deacetylase HDAC inhibitors 59 antitumor activity 59 Neuvenge 59 imatinib therapy 59 CTLA 4 59 thymidylate synthase 59 therapeutic monoclonal antibody 59 MMP inhibitors 59 MLN# 59 xenograft models 59 Tykerb 59 ToGA 59 sorafenib Nexavar ® 59 Aplidin 59 PKCi 59 anti TNF alpha 59 integrase inhibitors 59 Vectibix 59 Arranon 59 RhuDex ® 59 mesothelin 59 Raltegravir 59 HQK 59 EndoTAGTM 1 59 antisense drug 59 ONX 59 posaconazole 59 dexamethasone Decadron 59 Virulizin ® 59 EGFR TKIs 59 Sutent sunitinib 59 chemotherapeutic agents 59 Smac mimetics 59 Ipilimumab 59 tumor vascular disrupting 59 MAb 59 predictive biomarkers 59 huN# DM1 59 satraplatin 59 Elesclomol 59 Doxil 59 pegylated liposomal doxorubicin 59 proteasome inhibitor bortezomib 59 hematological cancers 59 PEGylated 59 Onalta 59 LBH# 59 Hsp# inhibitor 59 Pfizer Sutent 59 daptomycin 59 Zalbin 59 microtubule targeting 59 Zybrestat 59 PRT# 59 Alpharadin 59 Anticalins 59 solid tumors 59 Taxotere docetaxel 59 CEQ# 59 standard chemotherapy regimen 59 echinocandin 59 Jevtana 59 panobinostat 59 INGN 59 amrubicin 59 chemotherapeutic 59 CR# vcMMAE 59 ZACTIMA 59 ISF# 59 anticancer 59 taxane chemotherapy 59 deacetylase inhibitors 59 demethylating agents 59 JAK3 inhibitor 59 SARMs 59 relapsing remitting multiple sclerosis 59 Nanobody ® 59 ISIS # 59 tigecycline 59 PD# [005] 59 chronic myelogenous leukemia CML 59 immunotherapeutic agent 59 taxol 59 vismodegib 59 tipranavir 59 visilizumab 59 Antiangiogenic 59 ocrelizumab 59 EGFR 59 EOquin TM 59 Fludara 59 Ixabepilone 59 abiraterone acetate 59 Avastin 59 RP# [002] 59 Ontak 59 LHRH 59 INT# [002] 59 protease inhibitors 59 nilotinib Tasigna ® 59 glucagon receptor 59 Iressa 59 Cloretazine ® 59 cisplatin 59 Alfimeprase 59 Squalamine 59 bispecific antibody 58 antitumor effect 58 tipifarnib 58 BRAF gene 58 HuMax EGFr 58 Lodamin 58 Dendreon Provenge 58 PSN# [002] 58 small molecule inhibitors 58 Phase Ib study 58 OHR/AVR# 58 ospemifene 58 CYT# potent vascular disrupting 58 Actemra 58 ALN TTR 58 Aliskiren 58 Gleevac 58 Antisense 58 bevacizumab Avastin ® 58 anti angiogenic agents 58 trastuzumab Herceptin ® 58 antagomirs 58 BiTE 58 immunosuppressant drug 58 TNF inhibitors 58 dasatinib Sprycel ® 58 targeted antifolate 58 alpha interferon 58 G CSF 58 neratinib 58 Icatibant 58 Degarelix 58 Zarnestra 58 GSK# [001] 58 Ridaforolimus 58 tocilizumab 58 inhibit EGFR 58 SCCHN 58 FK# 58 untreated metastatic melanoma 58 siRNA therapeutics 58 DAVANAT 58 polymerase inhibitors 58 Golimumab 58 AQ4N 58 AZD# 58 Tarceva TM 58 Alocrest 58 Rituxan rituximab 58 CDDO Im 58 rituximab 58 Taxol ® 58 aprepitant 58 glioblastoma 58 CUDC 58 EGFR pathway 58 MAXY G# 58 metastatic colorectal 58 gastrointestinal stromal tumors GIST 58 Trastuzumab DM1 58 trastuzumab Herceptin R 58 Fulvestrant 58 angiogenesis inhibitors 58 Axitinib 58 HIV protease 58 paclitaxel Taxol ® 58 HER2 positive breast cancer 58 chemopreventive agent 58 sunitinib malate 58 PEGylated Fab fragment 58 itraconazole 58 imatinib mesylate 58 favorable pharmacokinetic profile 58 Genentech Herceptin 58 budesonide foam 58 Tocosol Paclitaxel 58 relapsed multiple myeloma 58 cetuximab 58 IMGN# 58 Pralatrexate 58 R#/MEM # 58 Viprinex 58 phenoxodiol 58 Octreotide 58 Campath alemtuzumab 58 investigational monoclonal antibody 58 IGFBP2 58 SAR# [004] 58 anidulafungin 58 eltrombopag 58 mycophenolate mofetil 58 figitumumab 58 MyVax 58 FOLFOX chemotherapy 58 IRESSA 58 enzyme inhibitor 58 leukemia AML 58 tyrosine kinase inhibitor TKI 58 trastuzumab 58 integrin receptors 58 ON #.Na 58 monoclonal antibody 58 KRAS mutation 58 KRN# 58 nilotinib 58 Phase Ib clinical 58 verteporfin 58 docetaxel Taxotere 58 ImmunoVEX HSV2 58 TLR9 agonists 58 superficial bladder cancer 58 iSONEP 58 MyVax R 58 potent anti angiogenic 58 anti CD3 58 xanthine oxidase inhibitor 58 Victrelis 58 CCR2 58 canagliflozin 58 TYZEKA 58 Taxol paclitaxel 58 PD LID 58 Ceflatonin R 58 virotherapy 58 interferon alfa 58 Hedgehog pathway 58 fosbretabulin 58 DU #b 58 ProLindac 58 TELCYTA 58 SAR# [002] 58 ImClone Erbitux 58 CHOP chemotherapy 58 Allovectin 7 58 T#I mutant 58 Leukine 58 tyrosine kinase inhibitors TKIs 58 Davanat 58 MNTX 58 Ocrelizumab 58 EGFR mutation 58 relapsed MM 58 orally dosed 58 Archexin 58 Asentar 58 atrasentan 58 Taxotere ® 58 MUC1 58 Fenretinide 58 GW# [003] 58 Atiprimod 58 evaluating tivozanib 58 ALD# 58 maraviroc 58 Vidaza azacitidine 58 eprotirome 58 QVA# 58 LymphoStat B 58 Cloretazine R 58 factor Xa 58 VIDAZA 58 anti mitotic 58 Voreloxin 58 chemotherapeutics 58 NSCLC tumors 58 PLK1 SNALP 58 Pixantrone 58 ProMune 58 Avastin Tarceva 58 Pirfenidone 58 Aplidin R 58 MT#/MEDI-# 58 IGF IR 58 AKT inhibitor 58 muraglitazar 58 antiangiogenic agents 58 AVN# [001] 58 NGX# 58 AVE# 58 selective modulator 58 Gemzar ® 58 Tamibarotene 58 pegylated 58 Tesetaxel 58 imatinib Gleevec ® 58 sipuleucel T 58 Cetuximab 58 Tykerb lapatinib 58 baminercept 58 nab paclitaxel 58 DACH platinum 58 estramustine 58 Kevetrin 58 lintuzumab 58 mAbs 58 midstage trials 58 nitazoxanide 58 Novartis Zometa 58 capecitabine Xeloda 58 Quinamed 58 etoposide 58 CDK4 58 chemotherapeutic regimen 58 EGFR inhibitor 58 Eribulin 58 CD# monoclonal antibody 58 Firazyr 58 bucindolol 57 NS4A 57 HER2/neu 57 insulin sensitizers 57 multiple myeloma MM 57 radiolabeled TM# 57 antisense oligonucleotide 57 Curaxin CBLC# 57 CXCR4 receptor 57 Mylotarg 57 antibody MAb 57 anticancer drugs 57 immune modulating 57 docetaxel 57 pegylated interferon alpha 57 Syk kinase 57 Azacitidine 57 thymalfasin 57 bicalutamide 57 pharmacokinetic interactions 57 MYDICAR ® 57 IL# PE#QQR 57 nab docetaxel 57 GLYX 57 K ras mutations 57 BN# [002] 57 Camptosar 57 ceftazidime 57 CIMZIA TM 57 PI3K inhibitors 57 aurora kinase 57 MabThera rituximab 57 Betaferon ® 57 aleglitazar 57 gemcitabine 57 tubulin inhibitor 57 EP #R 57 rFIXFc 57 Ataluren 57 aptamer 57 vicriviroc 57 capecitabine Xeloda R 57 oxaliplatin 57 PEG Interferon lambda 57 PNP inhibitor 57 IFN α 57 Xelox 57 ReoPro 57 HCD# [002] 57 L BLP# 57 potent anticancer 57 HspE7 57 R#/MEM 57 metastatic melanoma 57 E#F# 57 DAPT 57 oncolytic virus 57 Doxil ® 57 basiliximab 57 relapsed leukemia 57 delafloxacin 57 Exelixis XL# 57 golimumab 57 ANG# 57 intratumoral injection 57 ABRAXANE ® 57 nucleoside analogue 57 VEGF inhibitor 57 Docetaxel 57 Guanilib 57 Panzem NCD 57 echinocandins 57 investigational protease inhibitor 57 investigational pan BCR 57 Angiocept 57 TRAIL receptor antibodies 57 torezolid 57 orally administered inhibitor 57 TroVax 57 tecarfarin 57 pradefovir 57 anti CD# antibodies 57 adalimumab Humira 57 Cotara 57 Exemestane 57 interferons 57 fluoropyrimidine 57 Aptivus ® 57 Bavituximab 57 potent antiproliferative 57 Stapled Peptide 57 HCV protease 57 perampanel 57 selective inhibition 57 eIF 4E 57 gastrointestinal stromal tumor GIST 57 interferon 57 CXCR4 57 Phase IIa trials 57 anti EGFR antibody 57 Ustekinumab 57 Panitumumab 57 uric acid lowering 57 inhibitor RG# 57 Aurora Kinase 57 Tasimelteon 57 sulindac 57 generation antisense 57 molecularly targeted therapy 57 ATL/TV# 57 Granulocyte Colony Stimulating Factor 57 Rapamycin 57 virus HCV protease inhibitor 57 synthetic peptide 57 subcutaneous formulation 57 c MYC 57 FGFR 57 Phase Ib clinical trials 57 pharmacodynamic effects 57 mecamylamine 57 ESBA# 57 ATL# [002] 57 RAV# 57 indolent NHL 57 Satraplatin 57 JAK2 inhibitor 57 melanoma tumors 57 YONDELIS R 57 tumor antigen 57 TG# [001] 57 Cloretazine 57 Imiquimod 57 investigational compound 57 immunomodulatory 57 durable remissions 57 immunotoxin 57 A3 adenosine receptor 57 Marqibo 57 inhibit metastasis 57 Temsirolimus 57 calcitriol 57 Phenoptin 57 ras gene 57 bone metastasis 57 cetuximab Erbitux R 57 vascular disrupting 57 FOLOTYN 57 DCCR 57 Combidex 57 eculizumab 57 teplizumab 57 AEGR 57 drug conjugate 57 EGFR protein 57 beta interferons 57 GGF2 57 Carboplatin 57 protease inhibitor 57 thrombin receptor 57 miR #b [002] 57 JAK2 inhibitors 57 FAAH 57 novel VDA molecule 57 DP b# 57 anakinra 57 nicotinic alpha 7 57 Specifid 57 Taxol 57 VEGF receptor inhibitor 57 nucleoside analogs 57 CCR5 inhibitor 57 blinatumomab 57 myeloma cells 57 Amevive 57 tranilast 57 ProSavin 57 BRIM2 57 biologic therapies 57 therapeutic antibody 57 HIV integrase inhibitor 57 desmoteplase 57 Phase IIb clinical trials 57 chronic myeloid leukemia CML 57 Dacogen decitabine 57 CD# antibodies 57 concurrent chemoradiation 57 immunomodulating 57 CDK inhibitors 57 cell lymphoma CTCL 57 HER2 receptor 57 Ceplene/IL-2 57 telcagepant 57 DEB# 57 Vfend 57 NeuroVax TM 57 DAVANAT ® 57 chemically modified siRNA 57 ELND# 57 small molecule tyrosine 57 PDGF receptor 57 TNFa 57 TLE3 57 TRC# 57 IFN alpha 57 Campath ® 57 p# inhibitors